Athanasios Frydas: Is It Safe to Skip TEE Before Rhythm Control in Low Thromboembolic Risk Patients?
Athanasios Frydas, Cardiologist at the German Heart Center at Charité (DHZC), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our latest publication in Heart Rhythm Open.
Is it safe to omit transesophageal echocardiography (TEE) prior to elective rhythm control interventions in anticoagulated patients without risk factors for thromboembolism?
Current guidelines remain inconclusive, and clinical practice varies widely between centers.
In our retrospective analysis of 645 patients who underwent same-session transthoracic (TTE) and transesophageal echocardiography (TEE), we observed a surprisingly high prevalence of clinically relevant left atrial appendage findings—even among patients considered low risk.
Notably, left atrial strain emerged as the strongest parameter associated with thromboembolic substrate.
These findings suggest that assessing left atrial cardiomyopathy using TTE could play a key role in improving patient selection for TOE necessity prior to rhythm control interventions.
Many thanks to all the coauthors for their contribution.”
Title: Transthoracic signs of left atrial cardiomyopathy predict presence of left atrial thromboembolic substrate
Authors: Athanasios Frydas, Alice Sokour, Fabian Spinka, Victor Schweiger, Hong Ran, Florian Blaschke, Henryk Dreger, Leif-Hendrik Boldt, Abdul Shokor Parwani, Gerhard Hindricks, Daniel-Armando Morris, Ingo Hilgendorf, Matthias Schneider-Reigbert
Read the Full Article on Heart Rhythm O2

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis